• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨髓增殖性肿瘤患者超声心动图显示肺动脉高压可能性高的患病率及危险因素

Prevalence and risk factors of high echocardiographic probability of pulmonary hypertension in myeloproliferative neoplasms patients.

作者信息

Jindamai Yanika, Rattarittamrong Ekarat, Phrommintikul Arintaya, Yongsmith Lalita, Piriyakhuntorn Pokpong, Rattanathammethee Thanawat, Hantrakool Sasinee, Chai-Adisaksopha Chatree, Tantiworawit Adisak, Norasetthada Lalita

机构信息

Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, 110 Inthawaroros Street, Muang, Chiang Mai, 50200, Thailand.

出版信息

Int J Hematol. 2020 Nov;112(5):631-639. doi: 10.1007/s12185-020-02952-4. Epub 2020 Jul 23.

DOI:10.1007/s12185-020-02952-4
PMID:32700192
Abstract

Pulmonary hypertension (PH) is emerging as a complication of myeloproliferative neoplasms (MPNs). This was a prospective study conducted at Chiang Mai University Hospital. The primary objective was to determine the prevalence of high echocardiographic probability of PH in MPNs patients. The secondary objectives were to determine risk factors of PH and the correlation between risk factors and peak tricuspid regurgitation velocity (TRV). All MPNs patients aged over 18 years, including polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF), were enrolled. All eligible patients underwent echocardiography for evaluation of the probability of PH in line with the 2015 European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Guidelines. Sixty-six patients with a median age of 59 years were enrolled. There were 35 PV, 25 ET, and 6 PMF patients included. The prevalence of high echocardiographic probability of PH was 4.55% (2 ET and 1 PMF). Risk factors associated with high echocardiographic probability of PHT were not analyzed. There were three risk factors associated with increased TRV specifically lower hemoglobin, older age, and the presence of JAK2V617F mutation. The prevalence of high echocardiographic probability of PH in MPNs patients was 4.55%.

摘要

肺动脉高压(PH)正逐渐成为骨髓增殖性肿瘤(MPN)的一种并发症。这是一项在清迈大学医院进行的前瞻性研究。主要目的是确定MPN患者中超声心动图提示PH可能性高的患病率。次要目的是确定PH的危险因素以及危险因素与三尖瓣反流峰值速度(TRV)之间的相关性。纳入所有年龄超过18岁的MPN患者,包括真性红细胞增多症(PV)、原发性血小板增多症(ET)和原发性骨髓纤维化(PMF)。所有符合条件的患者均接受超声心动图检查,以根据2015年欧洲心脏病学会(ESC)和欧洲呼吸学会(ERS)指南评估PH的可能性。共纳入66例患者,中位年龄为59岁。其中包括35例PV患者、25例ET患者和6例PMF患者。超声心动图提示PH可能性高的患病率为4.55%(2例ET患者和1例PMF患者)。未分析与超声心动图提示PHT可能性高相关的危险因素。有三个与TRV升高相关的危险因素,具体为血红蛋白水平较低、年龄较大以及存在JAK2V617F突变。MPN患者中超声心动图提示PH可能性高的患病率为4.55%。

相似文献

1
Prevalence and risk factors of high echocardiographic probability of pulmonary hypertension in myeloproliferative neoplasms patients.骨髓增殖性肿瘤患者超声心动图显示肺动脉高压可能性高的患病率及危险因素
Int J Hematol. 2020 Nov;112(5):631-639. doi: 10.1007/s12185-020-02952-4. Epub 2020 Jul 23.
2
Clinical Manifestations and Risk Factors for Complications of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.费城染色体阴性骨髓增殖性肿瘤的临床表现及并发症危险因素
Asian Pac J Cancer Prev. 2015;16(12):5013-8. doi: 10.7314/apjcp.2015.16.12.5013.
3
[Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].[JAK2V617F突变在慢性骨髓增殖性肿瘤患者中的意义]
Orv Hetil. 2011 Nov 6;152(45):1795-803. doi: 10.1556/OH.2011.29226.
4
Thrombosis in the Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.费城染色体阴性骨髓增殖性肿瘤中的血栓形成
Cancer Treat Res. 2019;179:159-178. doi: 10.1007/978-3-030-20315-3_11.
5
Prevalence and risk factors for Pulmonary Hypertension associated with chronic Myeloproliferative Neoplasms.慢性骨髓增生性肿瘤相关肺动脉高压的患病率和危险因素。
Eur J Haematol. 2021 Feb;106(2):250-259. doi: 10.1111/ejh.13543. Epub 2020 Nov 22.
6
Risk factors for ischemic stroke in patients with Philadelphia chromosome (Ph)-negative myeloproliferative neoplasms.费城染色体(Ph)阴性骨髓增殖性肿瘤患者发生缺血性卒中的危险因素。
J Clin Neurosci. 2024 Jul;125:159-166. doi: 10.1016/j.jocn.2024.05.025. Epub 2024 May 29.
7
The impact of JAK2V617F mutation on Philadelphia-negative myeloproliferative neoplasms.JAK2V617F 突变对费城阴性骨髓增殖性肿瘤的影响。
Turk J Med Sci. 2022 Feb;52(1):150-165. doi: 10.3906/sag-2103-247. Epub 2022 Feb 22.
8
Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisal.骨髓增殖性肿瘤中JAK2V617F存在或等位基因负担的临床相关性:一项批判性重新评估。
Leukemia. 2008 Jul;22(7):1299-307. doi: 10.1038/leu.2008.113. Epub 2008 May 22.
9
Changing incidence of myeloproliferative neoplasms: trends and subgroup risk profiles in the USA, 1973-2011.1973 - 2011年美国骨髓增殖性肿瘤发病率的变化:趋势及亚组风险概况
J Cancer Res Clin Oncol. 2015 Dec;141(12):2131-8. doi: 10.1007/s00432-015-1983-5. Epub 2015 May 13.
10
Frequency and etiology of pulmonary hypertension in patients with myeloproliferative neoplasms.骨髓增殖性肿瘤患者肺动脉高压的频率和病因。
Eur J Haematol. 2019 Mar;102(3):227-234. doi: 10.1111/ejh.13197. Epub 2019 Jan 10.

引用本文的文献

1
Transformed to myelofibrosis is a risk factor for pulmonary hypertension in Philadelphia chromosome-negative myeloproliferative neoplasms.转化为骨髓纤维化是费城染色体阴性骨髓增殖性肿瘤患者发生肺动脉高压的一个危险因素。
Ann Hematol. 2025 Apr;104(4):2279-2285. doi: 10.1007/s00277-025-06334-w. Epub 2025 Apr 21.

本文引用的文献

1
Incidence of pulmonary hypertension in patients with chronic myeloproliferative disorders.慢性骨髓增殖性疾病患者肺动脉高压的发病率。
Haematologica. 2004 Feb;89(2):245-6.